<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27889" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Proteus mirabilis Infections</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jamil</surname>
            <given-names>Radia T.</given-names>
          </name>
          <aff>Allama Iqbal Medical College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Foris</surname>
            <given-names>Lisa A.</given-names>
          </name>
          <aff>St. George's University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Snowden</surname>
            <given-names>Jessica</given-names>
          </name>
          <aff>University of Nebraska Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Radia Jamil declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Lisa Foris declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jessica Snowden declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27889.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Proteus mirabilis is a gram-negative facultative anaerobe with swarming motility and an ability to self-elongate and secrete a polysaccharide which allows it to attach to and move along surfaces like catheters, intravenous lines, and other medical equipment. The most definitive form of evaluation for an acute P. mirabilis infection is a culture. However, positive culture results must be considered in conjunction with a patient's presentation for an accurate diagnosis to be made. This activity describes the presentation and evaluation of Proteus infections and highlights the role of the interprofessional team in the management of infected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the epidemiology of proteus infections in non-hospitalized versus hospitalized patients.</p></list-item><list-item><p>Describe the clinical manifestations of Proteus infections.</p></list-item><list-item><p>Outline the treatment considerations for Proteus infections in hospitalized versus non-hospitalized patients.</p></list-item><list-item><p>Explain the need for a well-integrated, interprofessional team approach to improve care for patients with Proteus infections.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27889&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27889">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27889.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Proteus mirabilis</italic>, part of the <italic toggle="yes">Enterobacteriaceae</italic> family of bacilli, is a gram-negative, facultative anaerobe with an ability&#x000a0;to ferment maltose and inability&#x000a0;to ferment lactose.&#x000a0;<italic toggle="yes">P. mirabilis</italic> also has swarming motility and the ability to self-elongate and secrete a polysaccharide when in contact with solid surfaces; this allows for attachment and easy motility along surfaces (e.g., medical equipment). The flagella of <italic toggle="yes">P. mirabilis</italic> are what allow for its motility; not only does this help support colonization, but it also has been associated with its ability to form biofilms and is suggested to contribute to resistance to host defenses and certain antibiotics.<xref ref-type="bibr" rid="article-27889.r1">[1]</xref><xref ref-type="bibr" rid="article-27889.r2">[2]</xref><xref ref-type="bibr" rid="article-27889.r3">[3]</xref><xref ref-type="bibr" rid="article-27889.r4">[4]</xref></p>
        <p><italic toggle="yes">Proteus </italic>is found abundantly in soil and water, and although it is part of the normal human intestinal flora (along with <italic toggle="yes">Klebsiella</italic> species, and <italic toggle="yes">Escherichia coli</italic>), it has been known to cause serious infections in humans.</p>
      </sec>
      <sec id="article-27889.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Ninety percent of <italic toggle="yes">Proteus</italic> infections occur as a result of <italic toggle="yes">P. mirabilis, </italic>and these are considered community-acquired infections<italic toggle="yes">. <xref ref-type="bibr" rid="article-27889.r4">[4]</xref><xref ref-type="bibr" rid="article-27889.r5">[5]</xref><xref ref-type="bibr" rid="article-27889.r6">[6]</xref></italic></p>
        <p>Though not a common cause of nosocomial infections, <italic toggle="yes">Proteus</italic> species have also been shown to cause infection from the colonized skin and oral mucosa of patients and personnel working in a hospital or long-term care facility.</p>
        <p>Patients who acquire an infection in the hospital, have a history of recurrent infections, structural abnormalities of the urinary tract, or urethral instrumentation have a greater risk of acquiring an infection by <italic toggle="yes">Proteus</italic> (in addition to other organisms such as <italic toggle="yes">Klebsiella</italic>, <italic toggle="yes">Enterobacter</italic>, <italic toggle="yes">Pseudomonas</italic>, <italic toggle="yes">Staphylococci</italic>, and <italic toggle="yes">Enterococci</italic>)<italic toggle="yes">.</italic></p>
        <p>Urinary tract infections (UTIs) occur as a result of bacterial migration along the mucosal sheath of the catheter or up the catheter lumen from contaminated urine.<xref ref-type="bibr" rid="article-27889.r7">[7]</xref><xref ref-type="bibr" rid="article-27889.r8">[8]</xref></p>
      </sec>
      <sec id="article-27889.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The most common clinical manifestations of <italic toggle="yes">Proteus</italic> infection are urinary tract infections (UTIs). In general, UTIs are more common in individuals aged 20 to 50 years and most common in women of this age group. In otherwise healthy women, <italic toggle="yes">Proteus</italic> accounts for 1% to 2% of all UTIs (<italic toggle="yes">E.</italic><italic toggle="yes">&#x000a0;coli</italic> being the most common), while in hospital-acquired UTIs, <italic toggle="yes">Proteus</italic> accounts for 5%. Complicated UTIs (i.e., secondary to catheterization) have an even higher association with <italic toggle="yes">Proteus </italic>infection at 20% to 45%.</p>
        <p>Risk factors for UTIs include sexual activity in both men and women, unprotected anal intercourse in men, an uncircumcised penis, or immunodeficiency (e.g., CD4 count less than 200/uL).</p>
        <p>Other factors that may increase the risk of infection by <italic toggle="yes">P. mirabilis</italic> include female sex, longer duration of catheterization, improper catheter cleaning or care, underlying illness, and lack of availability of systemic antibiotics.</p>
        <p>In the United States, gram-negative bacteremia occurs as a result of genitourinary tract infections in 35% of patients.</p>
      </sec>
      <sec id="article-27889.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The interaction between <italic toggle="yes">P.</italic>
<italic toggle="yes">mirabilis </italic>and the host defense (immune) system determines the resultant infection. <italic toggle="yes">Proteus</italic> species have an extracytoplasmic outer membrane, like other gram-negative bacteria, which contains lipoproteins, polysaccharides, lipopolysaccharides, and a lipid bilayer. Different components of this membrane interact with the host and host defense mechanisms to determine the organism&#x02019;s virulence. Additionally, the size of the inoculum has a positive correlation with the level of infection.</p>
        <p>Attachment of <italic toggle="yes">P. mirabilis</italic> to host tissue depends on the activity of its fimbriae (or pili), which are&#x000a0;tiny projections on the bacterium surface.&#x000a0; The tips of these fimbriae also contain certain compounds and polysaccharides that allow for attachment to specific sites in the host organism (e.g., endothelium of the urinary tract) or other inanimate surfaces (e.g., medical devices).</p>
        <p>Once <italic toggle="yes">Proteus</italic> species attach to the target site, a cascade of events is initiated in the host cell, including interleukin (IL) 6 and IL-8 secretion in addition to apoptosis and epithelial cell desquamation.&#x000a0;<italic toggle="yes">Proteus</italic> species also produce urease, which has been shown to be associated with an increased risk of pyelonephritis and upper UTIs.&#x000a0;<italic toggle="yes">Proteus</italic> species also hydrolyze urea to ammonia, thereby alkalinizing the urine. Through the production of urease and ammonia, <italic toggle="yes">Proteus </italic>can produce an environment where it can survive. Additionally, alkaline urine will decrease the solubility of both organic and inorganic compounds, encouraging precipitation and struvite (e.g., magnesium ammonium phosphate and calcium carbonate-apatite) stone formation.</p>
        <p>Like other gram-negative bacteria, <italic toggle="yes">Proteus</italic> species release endotoxin (part of the gram-negative bacterial cell wall) when invading the bloodstream; thereby triggering additional host inflammatory responses which can ultimately result in sepsis or systemic inflammatory response syndrome (SIRS), a severe condition with a 20% to 50% associated incidence of mortality.</p>
      </sec>
      <sec id="article-27889.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Individuals with a <italic toggle="yes">Proteus</italic> infection may present with urethritis, cystitis, prostatitis, or pyelonephritis. A history of frequent renal stones may be indicative of an underlying chronic <italic toggle="yes">Proteus</italic> infection.</p>
        <p>Urethritis typically presents with dysuria, pyuria (with or without urethral discharge), and increased urinary frequency. Symptoms are often mild and frequently ignored by patients.</p>
        <p>Cystitis, on the other hand, tends to present acutely with dysuria, increased frequency, and urgency of urination, suprapubic or back pain, small volume urine, dark urine, or hematuria. Patients&#x000a0;also&#x000a0;may present with a fever which may be indicative of a more severe condition, such as pyelonephritis, bacteremia, or impending sepsis.</p>
        <p>Prostatitis occurs more acutely in men than cystitis, with the same set of symptoms, though may also be accompanied by fever and chills. Prostatitis tends to be more common with increased age. If there is an associated obstruction, patients&#x000a0;also&#x000a0;may complain of perianal pain. A diffusely swollen and tender prostate may be noted on palpation during a physical examination.</p>
        <p>Pyelonephritis occurs as a complication of either of the conditions mentioned above, and the patient may, therefore, complain of symptoms of urethritis or cystitis. Additional symptoms that are more definitive of pyelonephritis include flank pain, costovertebral angle tenderness, nausea and vomiting, fever, hematuria, and occasionally an enlarged kidney felt on palpation.</p>
      </sec>
      <sec id="article-27889.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The most definitive form of evaluation for an acute <italic toggle="yes">P. mirabilis </italic>infection is a culture.&#x000a0;<italic toggle="yes">Proteus</italic> species are gram-negative, rod-shaped, and facultatively anaerobic. The majority of strains are lactose negative with characteristic swarming motility that will become evident on agar plates. One must always correlate positive culture results with the clinical presentation of the patient to form an&#x000a0;accurate diagnosis.</p>
        <p>Additional evaluations include urine sample analysis to evaluate for pyuria and leukocyte esterase. Pyuria is generally present in the case of bacterial urinary tract infection, such that lack of pyuria may indicate an alternate cause of symptoms. Leukocyte esterase dipstick provides a good alternative to microscopy but is a less sensitive test than microscopic examination. Gram staining of urine may help reveal microscopic bacteriuria which would confirm infection,&#x000a0;although the absence of bacteriuria does not exclude it.&#x000a0;</p>
        <p>A patient with a history of chronically alkaline urine in combination with a positive <italic toggle="yes">Proteus</italic> culture should be evaluated for renal stones (struvite stones).</p>
        <p>If resolution is not seen with antibiotic therapy alone, an ultrasound of the kidneys or a CT abdomen may be warranted to rule out renal stones or a perinephric abscess.</p>
      </sec>
      <sec id="article-27889.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Empirical treatment for an uncomplicated UTI caused by <italic toggle="yes">P. mirabilis</italic> (much like other uncomplicated UTIs) involves outpatient treatment with either a 3-day course of trimethoprim/sulfamethoxazole (TMP/SMZ) or an oral fluoroquinolone (e.g., ciprofloxacin).<xref ref-type="bibr" rid="article-27889.r9">[9]</xref><xref ref-type="bibr" rid="article-27889.r10">[10]</xref><xref ref-type="bibr" rid="article-27889.r11">[11]</xref></p>
        <p>Acute, uncomplicated pyelonephritis can be treated on an outpatient basis with fluoroquinolones, although a regimen of 7 to 14 days is recommended. An alternative to this treatment is a one-time dose of ceftriaxone or gentamycin followed by either TMP/SMZ, an oral fluoroquinolone, or cephalosporin for 7 to 14 days.</p>
        <p>If a patient has a more severe condition or is in an inpatient setting, they may begin antibiotic therapy via intravenous administration of either ceftriaxone, gentamycin, fluoroquinolone, gentamycin plus ampicillin, or aztreonam until fever resolves. At this point, they may switch to oral therapy with either cephalosporin, an oral fluoroquinolone, or TMP/SMZ for up to 14 additional days.</p>
        <p>If a patient presents with a complicated UTI (e.g., a man or woman with a history of an underlying condition that may increase the risk of failure of therapy), they may also be treated in an outpatient setting with oral antibiotics for 10 to 21 days as long as they receive adequate follow-up.</p>
        <p><italic toggle="yes">Proteus</italic> infection can be avoided with proper sanitation and hygiene, such as adequate sterilization of medical equipment and surfaces.&#x000a0; Additionally, catheterization should be reserved for patients for whom there is no other option.</p>
      </sec>
      <sec id="article-27889.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Other Gram-negative bacteria, such as E. coli or Klebsiella species, may cause similar clinical presentations with UTI and/or bacteremia. Bacterial culture is essential to identify the causative organism of infection and target therapy appropriately.&#x000a0;</p>
      </sec>
      <sec id="article-27889.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The vast majority of proteus infections are associated with the urinary tract. Most of the infections are sensitive to the currently available antibiotics and the outcomes are good in immunocompetent patients.</p>
      </sec>
      <sec id="article-27889.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Symptoms generally resolve without complications in immunocompetent patients. Immunocompromised patients can be at higher risk for sepsis or prolonged infections.&#x000a0;</p>
      </sec>
      <sec id="article-27889.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Decreasing risk factors such as prolonged catheterization can decrease the risk of infection.&#x000a0;</p>
      </sec>
      <sec id="article-27889.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Proteus infections are best managed by an interprofessional team that includes physicians, nurses, and pharmacists. Infectious disease specialists may also be helpful, particularly in cases of resistant infections, device-associated infections, or immunocompromised patients.&#x000a0;</p>
      </sec>
      <sec id="article-27889.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27889&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27889">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/proteus-mirabilis-infections/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27889">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27889/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27889">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27889.s15">
        <title>References</title>
        <ref id="article-27889.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marcon</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schubert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Stief</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Magistro</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>In vitro efficacy of phytotherapeutics suggested for prevention and therapy of urinary tract infections.</article-title>
            <source>Infection</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>47</volume>
            <issue>6</issue>
            <fpage>937</fpage>
            <page-range>937-944</page-range>
            <pub-id pub-id-type="pmid">31069724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Majeed</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Aljanaby</surname>
                <given-names>AAJ</given-names>
              </name>
            </person-group>
            <article-title>Antibiotic Susceptibility Patterns and Prevalence of Some Extended Spectrum Beta-Lactamases Genes in Gram-Negative Bacteria Isolated from Patients Infected with Urinary Tract Infections in Al-Najaf City, Iraq.</article-title>
            <source>Avicenna J Med Biotechnol</source>
            <year>2019</year>
            <season>Apr-Jun</season>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>192</fpage>
            <page-range>192-201</page-range>
            <pub-id pub-id-type="pmid">31057723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pavez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Troncoso</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Osses</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Salazar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Illesca</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Reydet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chahin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Concha</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barrientos</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>High prevalence of CTX-M-1 group in ESBL-producing enterobacteriaceae infection in intensive care units in southern Chile.</article-title>
            <source>Braz J Infect Dis</source>
            <year>2019</year>
            <season>Mar-Apr</season>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>102</fpage>
            <page-range>102-110</page-range>
            <pub-id pub-id-type="pmid">31028724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>An evaluation of multidrug-resistant (MDR) bacteria in patients with urinary stone disease: data from a high-volume stone management center.</article-title>
            <source>World J Urol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>38</volume>
            <issue>2</issue>
            <fpage>425</fpage>
            <page-range>425-432</page-range>
            <pub-id pub-id-type="pmid">31025083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Potron</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hocquet</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Triponney</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pl&#x000e9;siat</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bertrand</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Valot</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>63</volume>
            <issue>6</issue>
            <pub-id pub-id-type="pmid">30962345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>O'Keefe</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Koelle</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>McGee</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Dewberry</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Wright</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stallings</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Gates</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chittur</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Innovations in Worksite Diagnosis of Urinary Tract Infections and the Occupational Health Nurse.</article-title>
            <source>Workplace Health Saf</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>67</volume>
            <issue>6</issue>
            <fpage>268</fpage>
            <page-range>268-274</page-range>
            <pub-id pub-id-type="pmid">30924742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Odoki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Almustapha Aliero</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tibyangye</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nyabayo Maniga</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wampande</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Drago Kato</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Agwu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bazira</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of Bacterial Urinary Tract Infections and Associated Factors among Patients Attending Hospitals in Bushenyi District, Uganda.</article-title>
            <source>Int J Microbiol</source>
            <year>2019</year>
            <volume>2019</volume>
            <fpage>4246780</fpage>
            <pub-id pub-id-type="pmid">30906323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tascini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sozio</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rossolini</surname>
                <given-names>GM</given-names>
              </name>
            </person-group>
            <article-title>AmpC &#x003b2;-lactamase-producing Enterobacterales: what a clinician should know.</article-title>
            <source>Infection</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>363</fpage>
            <page-range>363-375</page-range>
            <pub-id pub-id-type="pmid">30840201</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pelling</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nzakizwanayo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Milo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Denham</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>MacFarlane</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Bock</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>BV</given-names>
              </name>
            </person-group>
            <article-title>Bacterial biofilm formation on indwelling urethral catheters.</article-title>
            <source>Lett Appl Microbiol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>68</volume>
            <issue>4</issue>
            <fpage>277</fpage>
            <page-range>277-293</page-range>
            <pub-id pub-id-type="pmid">30811615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duarte</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kozin</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Barshak</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Reinshagen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Knoll</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Abdullah</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Welling</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Otogenic brain abscesses: A systematic review.</article-title>
            <source>Laryngoscope Investig Otolaryngol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>198</fpage>
            <page-range>198-208</page-range>
            <pub-id pub-id-type="pmid">30062135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27889.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Armbruster</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Mobley</surname>
                <given-names>HLT</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of <italic>Proteus mirabilis</italic> Infection.</article-title>
            <source>EcoSal Plus</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>8</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">29424333</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
